864910-76-9Relevant academic research and scientific papers
Synthesis of α-aminonitriles via a FeSO4-mediated oxidative cyanation of tertiary amines with benzoyl cyanide and molecular oxygen or TBHP
Zhang, Lianpeng,Gu, Xin,Lu, Ping,Wang, Yanguang
, p. 2359 - 2363 (2016/04/19)
An iron-mediated oxidative cyanation of tertiary amines with benzoyl cyanide and molecular oxygen or TBHP has been achieved. This reaction furnished α-cyanated tertiary amines under mild reaction conditions in good to excellent yields (up to 94%) with gre
Ruthenium complexes with an anthyridine-based ligand. Synthesis, characterization and catalytic activity
Lo, Ying-Hao,Liu, Yi-Hung,Peng, Shie-Ming,Liu, Shiuh-Tzung
, p. 839 - 845 (2013/11/06)
Complexation of 2, 7-bis(2-pyridinyl)-9-phenylanthyridine (4) with [RuCl2(CO)3(THF)] and [(η6-p-cy-mene) RuCl2]2 provided the mono-nuclear complex [(4)Ru(CO) 3Cl][RuCl3(CO)3
Azobisisobutyronitrile initiated aerobic oxidative transformation of amines: Coupling of primary amines and cyanation of tertiary amines
Liu, Lianghui,Wang, Zikuan,Fu, Xuefeng,Yan, Chun-Hua
supporting information, p. 5692 - 5695 (2013/01/15)
In the presence of a catalytic amount of radical initiator AIBN, primary amines are oxidatively coupled to imines and tertiary amines are cyanated to α-aminonitriles. These "metal-free" aerobic oxidative coupling reactions may find applications in a wide
Ion Channel Modulators
-
Page/Page column 51, (2010/11/29)
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.
ION CHANNEL MODULATORS
-
Page/Page column 56, (2010/02/14)
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.
